Role of B Lymphocyte stimulator factor in systemic lupus erythematosis patients.
- Rheumatology and Rehabilitation department Egypt. \ Clinical Pathology department Faculaty of medicin Zagazig university hospitals Egypt.
7 Downloads
92 Views
Abstract
Bachground. The pathogenesis of systemic lupus erythematosus [S L E ] is complex .Target tissue damageis caused primarily by pathogenic autoantibodies and immune complexes. B cells play a central role in SLE
Objectives. this cross sectional study aimed to detrmined level of serum b lymphocyte stimulator and find any correlation with activity and severity in SLEpatients
Subjects. This study was done on 35 SLEpatients and 35 apparently healthy controls
Methods.All patients subjeced to full history taking ,general examination, locomotor examination, routine laboratory inestigations ,assessment of serum level of b lymphocyte stimulator factorby ELISA
results. Serum levels of lymphocyte stimulator were significantly higher in SLE patients than normal subjects
Also there was significant correlation with SLEDAI,CRB,ANA and Anti- dna .But no significant correlation with C3, C4 , age, disease duration
Conclusion.This results may prove the possibility that a human monoclonal antibody drug which selectively inhibits BLyS biological activity may be useful in treatment of active resistant cases
Article Analytics
How to Cite This Article
Nahla M-Gaballa., Fadia A- Gooda., Wessam M-Ibrahim and Ahmad M-Gaballa. (2016); Role of B Lymphocyte stimulator factor in systemic lupus erythematosis patients., Int. J. of Adv. Res., 4 (05), 1823-1826, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/400
Corresponding Author
This work is licensed under a Creative Commons Attribution 4.0 International License.





